FEBRUARY 2025 NEWSLETTER
The newsletter of the Feinberg School of Medicine Research Office
 |
Investigating the Youth Mental Health Crisis |
|
Many have posited the reason for rising mental health concerns among kids and teens – social media, the COVID-19 pandemic, stigma, etc. But the reality is there is a constellation of factors that contribute to this crisis, according to experts. |
 |
Young Physician-Scientist Awards Honor Feinberg Pathologists |
|
Jonathan Chen, MD, PhD, assistant professor of Pathology in the Division of Molecular Pathology, and Waihay Wong, MD, PhD, assistant professor of Pathology, have been named recipients of the American Society of Clinical Investigation’s 2025 Young Physician-Scientist Award. |
Faculty ProfileUnderstanding How Sex Hormones Influence Reproductive Health and DiseaseJi-Yong Julie Kim, PhD, is the Susy Y. Hung Research Professor of Obstetrics and Gynecology in the Division of Reproductive Science in Medicine. Her laboratory aims to elucidate the molecular mechanisms associated with the development and growth of endometrial cancer, endometriosis and fibroids to identify novel therapeutic targets. |
|
Staff ProfileMentoring and Collaborating Across DepartmentsOlga Garcia is a senior research administrator within Sponsored Project and Research Catalysts (SPARC) at Feinberg. Having been at Feinberg since 2006, Garcia has served in numerous roles in research administration and finance. Now, she trains and mentors research administrators within SPARC and specializes in training grants. |
|
Student ProfileDeveloping New Biologics to Improve HealthClaire Phoumyvong is a fifth-year PhD candidate in the Driskill Graduate Program in Life Sciences (DGP). She joined the laboratory of Gabriel Rocklin, PhD, assistant professor of Pharmacology. She is studying mechanisms to deliver proteins into the cell as a new type of therapeutic modality. |
|
Campus Events |
||||||||
|
Research in the NewsChicago Tribune, February 12 WebMD, February 10 US News and World Report, January 31 |
NUCATS CornerScience In Translation PodcastOn season three of the Science in Translation podcast, Feinberg scientists discuss the tools investigators use to move transformational research discoveries into real-world solutions. Hear from Laura Rasmussen-Torvik, PhD, on career development, Cory Bradley, PhD, on health equity, and Leah Welty, PhD, and Anju Peters, MD, on how NUCATS empowers clinical and translational research at the university. |
|
Sponsored ResearchDevelopment of Cochlear Innervation
|
|
Breakthroughs PodcastPursuing Precision Medicine for Rare Diseases with Gemma Carvill, PhDScientists from Northwestern Medicine, the Broad Institute of MIT and Harvard have uncovered the first rare genetic disorder linked to a long non-coding RNA gene. In this episode, Gemma Carvill, PhD, explains how this discovery, published in The New England Journal of Medicine, came to be and the critical roles non-coding regions of the genome may have in human health |
|
New FacultyMohamed Abdel Mohsen, PhD, joined Feinberg in May 2024 as Margaret Gray Morton Professor of Medicine and associate professor of Medicine (Infectious Diseases). He is also a senior member of the Center for Human Immunobiology (CHI) and the Potocsnak Longevity Institute. His laboratory’s expertise in glycoimmunology and translational virology will fuel discoveries relevant to their respective missions. Prior to his position at Northwestern, Abdel-Mohsen was an associate professor in the Vaccine and Immunotherapy Center at the Wistar Institute, and served as the co-director of the University of Pennsylvania CFAR Virus and Reservoirs Technology Core. In January 2025, Abdel-Mohsen will become director of the Third Coast’s Center for AIDS Research Virology and Immunology Technology Core. |
|
Galter LibraryClarivate Analytics Announces 2024 Highly Cited ResearchersNorthwestern continues to be recognized as a leader in groundbreaking research, with multiple faculty members named to the 2024 Highly Cited Researchers list by Clarivate Analytics. This prestigious distinction highlights researchers whose work has had a profound and wide-ranging impact in their respective fields, as demonstrated by their consistent production of highly cited papers. |
|
High Impact ResearchKeate RL, Bury MI, Mendez-Santos M, Gerena A, Goedegebuure M, Rivnay J, Sharma AK, Ameer GA. Cell-free biodegradable electroactive scaffold for urinary bladder tissue regeneration. Nature Communications. January 2025; 16(1):11-11. Khan SS, Ndumele CE, Kazi DS. Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists. Journal of the American Medical Association. January 2025; 333(2):113-114. Kitata RB, Velickovic M, Xu Z, Zhao R, Scholten D, Chu RK, Orton DJ, Chrisler WB, Zhang T, Mathews JV, Bumgarner BM, Gursel DB, Moore RJ, Piehowski PD, Liu T, Smith RD, Liu H, Wasserfall CH, Tsai CF, Shi T. Robust collection and processing for label-free single voxel proteomics. Nature Communications. January 2025; 16(1):547-547. Li WS, Carter LM, Almassalha LM, Gong R, Pujadas-Liwag EM, Kuo T, MacQuarrie KL, Carignano M, Dunton C, Dravid V, Kanemaki MT, Szleifer I, Backman V. Mature chromatin packing domains persist after RAD21 depletion in 3D. Science Advances. January 2025; 11(4):eadp0855-eadp0855. |
Featured CoreDevelopmental Therapeutics CoreUnder the umbrella of Chemistry of Life Processes Institute (CLP), the Developmental Therapeutics Core (DTC) provides an operational laboratory that supports translational projects and fulfills the needs of the research community for exploratory drug development work. The aim is to rapidly and efficiently advance novel therapeutic interventions from basic research to the clinic. Services offered:
|
NIH NewsTo learn more about how the federal administration transition is impacting research here at Northwestern, visit the Office for Research website. Introducing the New NIH Public Access Policy NIH is releasing a new NIH Public Access to make the results of NIH-funded research accessible as quickly as possible. The new policy, which will replace the 2008 Public Access Policy upon effective date, removes the twelve-month embargo period to provide accelerated access to published manuscripts. Alongside the new policy, NIH is releasing its plan to make it easier for researchers, clinicians, students, and the public to find and make use of search results. More information on this plan and information on how to provide comments can be found here. |
Funding Opportunities
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)
Biology of Bladder Cancer (R21 Clinical Trial Optional)
|
Thank You For ReadingWe are testing an updated format for this newsletter. We welcome your feedback. Please share it with us via email. |
|
|
